Related Experiment Video
Updated: Sep 9, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
The use profile of antimicrobial drugs in neonatal intensive care units: A scoping review protocol
Insights
This scoping review examines antimicrobial drug use in Neonatal Intensive Care Units (NICUs). Findings will inform safer antimicrobial practices for vulnerable newborns facing infection risks.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pharmacology
Background:
- Newborns possess immature immune systems, increasing susceptibility to infections.
- Factors like invasive procedures, prolonged hospital stays, and low birth weight exacerbate infection risk in neonates.
- Antimicrobial drug utilization in Neonatal Intensive Care Units (NICUs) requires characterization.
Purpose of the Study:
- To conduct a scoping review of antimicrobial drug utilization in NICUs.
- To characterize the patterns and profiles of antimicrobial drug use in neonatal intensive care settings.
- To provide evidence for informed decision-making in antimicrobial prescribing for neonates.
Main Methods:
- Protocol registered on Open Science Framework (OSF) following Joanna Briggs Institute (JBI) methodology.
- Comprehensive search of multiple databases (PubMed, Scopus, Web of Science, etc.) and grey literature.
- Study selection and data extraction by two independent reviewers using Rayyan, adhering to PCC framework.
Main Results:
- Data extraction focused on antimicrobial consumption rates, common prescriptions, indications, and off-label use.
- Inclusion criteria specified studies from NICUs with stratifiable data for hospitalized neonates.
- Extracted data to be presented schematically and in tables with narrative descriptions.
Conclusions:
- Study outcomes will elucidate global variations in antimicrobial utilization in NICUs.
- Findings will support healthcare professionals in optimizing antimicrobial prescribing.
- The review aims to promote safer and more effective clinical practices for neonatal antimicrobial therapy.
Background:
Newborns are particularly susceptible to infections due to their immature immune systems. This condition is also exacerbated by the following factors (i) invasive procedures, (ii) length of hospital stay, and (iii) low birth weight.
Objective:
This study aims to characterize the utilization profile of antimicrobial drugs in neonatal intensive care units (NICUs) through a scoping review.
Methods:
The protocol, developed in accordance with the methodology outlined by the Joanna Briggs Institute, has been registered on the Open Science Framework (OSF) platform (DOI 10.17605/OSF.IO/YB4AG). The search will encompass databases including LILACS, EMBASE, MEDLINE/PubMed, Scientific Electronic Library Online (SciELO), as well as Web of Science and Scopus. Gray literature will be accessed through digital repositories. Search terms will be combined using Boolean operators 'OR' and 'AND,' aligned with the PCC framework (Population, Concept, Context). Identified studies will be managed using the Rayyan app, with duplicates removed. Two independent reviewers will handle study selection and data extraction. Studies will be included if they are available in full and contain at least one of the following pieces of information: data on antimicrobial consumption rates, the most prescribed antimicrobials, the most common indications for antimicrobial use, or off-label prescription of antimicrobials. Studies must have been conducted in NICUs with neonates hospitalized in this setting; if the study involves other settings or populations, the data must be stratifiable for neonates hospitalized in NICUs. The extracted data will be presented schematically or in tables, with a narrative description accompanying the results.
Implications:
The outcomes will contribute to understanding global variations in antimicrobial utilization, offering evidence to support health care professionals in making informed decisions regarding antimicrobial usage and promoting safer and more effective clinical practices.
More Related Videos
Related Concept Videos
Antimicrobial Effectiveness
Hand hygiene
Hand washing...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...

